Synam Vaccine
SynAm Vaccine, located in Rockville, Maryland, is dedicated to eradicating pneumococcal diseases such as pneumonia, middle ear infections, and meningitis through the development of the world's first universal vaccine. This innovative vaccine aims to provide comprehensive coverage against all 91 bacterial serotypes, addressing a significant unmet medical need in the marketplace where existing vaccines only target a limited number of serotypes.
Founded by a team of experienced professionals, including co-founders Don Chen and Ming-chi Wu, SynAm Vaccine is supported by a distinguished advisory board featuring prominent figures like Nobel Laureate Yuan Tseh Lee and medical expert David Ho. The company has gained recognition for its innovative approach and was awarded $25,000 in research services by Noble Life Sciences, alongside being selected for the 2012 Life Sciences Class of Springboard Enterprises.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
